课题基金 / 基金详情

Immunocytochemical study on the association between alpha-granule membrane proteins and adhesive proteins during platelet activation.

Immunocytochemical study on the association between alpha-granule membrane proteins and adhesive proteins during platelet activation.
血小板活化过程中α颗粒膜蛋白和粘附蛋白之间关联的免疫细胞化学研究。
批准号:
04671543
负责人:
SUZUKI Hidenori
金额:
$1.34万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993

项目摘要

项目成果

SUZUKI Hidenori的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We employed a double-staining method to immunocytochemically study the role of the alpha-granule membrane GPIIb/IIIa complex in the expression of intragranular fibrinogen (Fbg) onto the surface of thrombin-activated human platelets. In the resting platelets, GPIIb/IIIa was distributed evenly on the alpha-granule membrane as well as on the surface membrane including the open canalicular system (OCS), while Fbg was exclusively detected in the granule. At 30 sec after activation by 0.1 U/ml of thrombin under the non-stirring condition, Fbg was redistributed in association with the granule membrane GPIIb/IIIa. At 1 to 5 minutes, the Fbg associating with GPIIb/IIIa became increasingly expressed on the surface membrane. Nevertheless, abundant Fbg was still remaining in the lumen of the swollen OCS, the membrane of which had been already depleted of GPIIb/IIIa. Unlike Fbg, most of the abundant albumin in the alpha-granule was released into the surrounding medium without association to the membrane of either the alpha-granule or the surface. These results suggest that a small portion of the intragranular Fbg binds to Fbg receptors expressed on the activated GPIIb/IIIa on the alpha-granule membrane, resulting in the formation of the GPIIb/IIIa-Fbg complex, which is then moved through the OCS membrane and expressed on the surface membrane. Thus, alpha-granule membrane GPIIb/IIIa acts as a carrier of intragranular Fbg.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
鈴木 英紀: "血小板膜糖蛋白の免疫電顕法による解析" 日本血栓止血学会誌. 3. 202-209 (1992)
Hideki Suzuki:“通过免疫电子显微镜分析血小板膜糖蛋白”日本血栓和止血学会杂志 3. 202-209 (1992)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
鈴木英紀: "血小板膜糖蛋白の免疫電顕法による解析" 日本血栓止血学会誌. 3. 202-209 (1992)
Hideki Suzuki:“通过免疫电子显微镜分析血小板膜糖蛋白”日本血栓和止血学会杂志 3. 202-209 (1992)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
鈴木英紀: "血小板a顆粒蛋白の動態" 臨床病理(臨時増刊特集第92号). 1-14 (1992)
Hideki Suzuki:“血小板 A 颗粒蛋白的动力学”临床病理学(特刊第 92 期)(1992 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
鈴木英紀: "血小板alpha顆粒蛋白の動態" 臨床病理(臨時増刊特集第92号). 1-14 (1992)
Hideki Suzuki:“血小板α颗粒蛋白的动力学”临床病理学(特刊第92期)(1992年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
20
    Development of novel therapeutics for intractable neuropathic pain based on target protector RNA modulating HCN channel function
    • 批准号:
      20K09232
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2020
    • 负责人:
      SUZUKI Hidenori
    • 依托单位:
    Treatment of chronic pain utilizing GABAergic neuron derived from iPS
    • 批准号:
      17K10932
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2017
    • 负责人:
      SUZUKI Hidenori
    • 依托单位:
    Clarification of mechanisms of aneurysmal growth and rupture by quantification of 3D-domain hemodynamic irregularity
    • 批准号:
      17K10825
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2017
    • 负责人:
      SUZUKI Hidenori
    • 依托单位:
    Development of curative treatment against neuropathic pain through comprehensive functional analysis of human long non-coding RNAs
    • 批准号:
      16H05461
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.07万
    • 财政年份:
      2016
    • 负责人:
      SUZUKI Hidenori
    • 依托单位:
    国内基金
    海外基金
    超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
    • 批准号:
      82371103
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      阮静
    • 依托单位:
    骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
    • 批准号:
      82371799
    • 项目类别:
      面上项目
    • 资助金额:
      47.00万元
    • 批准年份:
      2023
    • 负责人:
      杨程德
    • 依托单位:
    脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
    • 批准号:
      82371223
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      闻大翔
    • 依托单位:
    利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
    • 批准号:
      82371145
    • 项目类别:
      面上项目
    • 资助金额:
      46.00万元
    • 批准年份:
      2023
    • 负责人:
      陶永
    • 依托单位: